[Clinical and demographic features of patients with stroke and atrial fibrillation]

D M Akpanova1, S F Berkinbayev1, A T Mussagaliyeva1

  • 1Scientific and Research Institute of Cardiology and Internal Diseases, Almaty.

Kardiologiia
|October 13, 2018
PubMed

Insights

Atrial fibrillation (AF) affects over 10% of stroke patients, significantly increasing in-hospital mortality risk. Few AF patients received preventive therapy, highlighting a critical gap in stroke prevention strategies.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Stroke is a leading cause of death and disability globally.
  • Atrial fibrillation (AF) is a major independent risk factor for ischemic stroke.
  • Stroke prevention remains a significant medical and societal challenge.

Purpose of the Study:

  • To determine the prevalence of atrial fibrillation (AF) in patients hospitalized with stroke or transient ischemic attack (TIA).
  • To assess the use of anticoagulant therapy in AF patients with stroke/TIA prior to hospitalization.
  • To evaluate the in-hospital mortality rates associated with AF in stroke/TIA patients.

Main Methods:

  • Retrospective analysis of 7,921 patient case reports from January 2013 to December 2015.
  • Selection of 849 case reports for patients diagnosed with both acute cerebrovascular disease/TIA and AF.
  • Utilized CHA2DS2‑VASc scale for risk stratification and analyzed mortality data.

Main Results:

  • The incidence of AF among stroke/TIA patients was 10.72%.
  • A high percentage (93.8%) of AF patients were classified as high-risk for thromboembolic complications.
  • Only 4.7% of AF patients received preventive therapy.
  • In-hospital mortality was significantly higher in patients with AF (15.78%) compared to those without AF (7.01%).

Conclusions:

  • Atrial fibrillation is a significant risk factor for in-hospital mortality in stroke/TIA patients.
  • There is a substantial gap in the preventive therapy uptake for thromboembolic complications in AF patients with stroke/TIA.
  • Improved screening and management of AF in stroke patients are crucial for reducing mortality.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.9K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
631
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
513
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
326
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
575